Drug discovery is a challenging and complex process that requires a lot of time, money, and expertise. According to some estimates, it takes an average of 10 years and $2.6 billion to bring a new drug to market. Moreover, only a small fraction of the potential drug candidates ever make it to the clinical trials stage, let alone get approved by the regulatory authorities.

One of the main bottlenecks in drug discovery is the design-make-test cycle of medicinal chemistry, which involves designing new molecules, synthesizing them in the lab, and testing them for biological activity and safety. This cycle can take months or even years to complete, and often results in many failures and dead ends.

PostEra is a biotech startup that aims to revolutionize drug discovery by using machine learning to close the design-make-test cycle and bring more cures to patients. PostEra’s platform leverages state-of-the-art algorithms to predict the best molecules for a given target, optimize their properties, and suggest the most efficient synthetic routes. By doing so, PostEra can significantly reduce the time and cost of drug discovery, as well as increase the chances of success.

PostEra has already demonstrated the power of its platform in several projects, such as the COVID Moonshot initiative, which is a global collaboration to find new antiviral drugs for COVID-19. PostEra’s platform has enabled the rapid identification and optimization of promising drug candidates, some of which have entered preclinical testing.

PostEra has also attracted the attention and support of some of the leading players in the healthcare and tech sectors. The company has raised $26 million from top investors such as Andreessen Horowitz, Founders Fund, and Y Combinator. It has also signed over $370 million in multi-year deals with partners such as Pfizer and the NIH, who are interested in using PostEra’s platform to accelerate their own drug discovery efforts.

PostEra is on a mission to build a modern 21st century biopharma that can deliver more effective and affordable treatments for various diseases. By harnessing the power of machine learning, PostEra hopes to make drug discovery faster, cheaper, and smarter than ever before.

Also Read: How Entera Helps You Find And Buy Your Dream Home